Trial Profile
Effect of lipid-lowering drug atorvastatin on VEGF levels as an adjunct to anti-VEGF injection in the management of diabetic macular edema
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Atorvastatin
- Indications Diabetic macular oedema
- Focus Pharmacodynamics
- 10 Jan 2020 Status changed from not yet recruiting to recruiting.
- 13 Nov 2018 New trial record